NCT05376969
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Daewoong pharmatceutical Seoul, South Korea
Clinical trial condition
Explore clinical trials studying T2DM (Type 2 Diabetes Mellitus). Study availability and eligibility vary by location and protocol.
NCT05376969
NCT04654390
NCT05279911
NCT04970940
NCT03437109
NCT03050229
NCT03233178
NCT03155087
Not specified